Recommendations for the management of patients with acute myeloid leukaemia (AML) during the COVID-19 outbreak

March 2020

This guidance identifies treatment strategies in adults with newly diagnosed AML which reduce NHS pressure whilst preserving patient outcomes. Mindful of the pace of change these recommendations will undergo regular review and should be considered valid until 5 April 2020.